These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27988307)

  • 21. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
    Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
    FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utrophin upregulation in Duchenne muscular dystrophy.
    Hirst RC; McCullagh KJ; Davies KE
    Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
    Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
    J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
    Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
    Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
    Weir AP; Morgan JE; Davies KE
    Neuromuscul Disord; 2004 Jan; 14(1):19-23. PubMed ID: 14659408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utrophin is a calpain substrate in muscle cells.
    Courdier-Fruh I; Briguet A
    Muscle Nerve; 2006 Jun; 33(6):753-9. PubMed ID: 16598790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle.
    Ljubicic V; Jasmin BJ
    Muscle Nerve; 2015 Jul; 52(1):139-42. PubMed ID: 25908446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Lowe DA; Kostek MC
    Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
    Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
    Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
    Baban D; Davies KE
    Neuromuscul Disord; 2008 Mar; 18(3):239-47. PubMed ID: 18343112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
    Péladeau C; Jasmin BJ
    Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.